Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rhenman & Partners Asset Management AB boosted its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 165,000 shares of the medical research company’s stock after acquiring an additional 5,000 shares during […]
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock with the greatest potential...
Trastuzumab deruxtecan improved PFS vs chemotherapy in pretreated, HR-positive, HER2-low or -ultralow metastatic breast cancer.
TFO Wealth Partners LLC raised its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 76,466.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,594 shares of the medical research company’s stock after acquiring an additional 4,588 shares during the […]
We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss why hedge funds have sizable positions in Exact Sciences Corporation (NASDAQ:EXAS). Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due to its need. According to a World […]